Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation

The GLORIA-AF registry

Dubner, S. J., Huisman, M. V., Diener, H. C., Halperin, J. L., Rothman, K. J., Ma, C. S., Bergler-Klein, J., Zint, K., Franca, L. R., Lu, S., Teutsch, C., Paquette, M., Lip, G. Y. H., & GLORIA-AF Investigators (2018). Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: The GLORIA-AF registry. European Heart Journal, 39, 606-607.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Protection of forest ecosystems in the eastern United States from elevated atmospheric deposition of sulfur and nitrogen
Article

The use of patient experience feedback in rehabilitation quality improvement and codesign activities
Article

SPTSSA variants alter sphingolipid synthesis and cause a complex hereditary spastic paraplegia
OCCASIONAL PAPER

Bringing an equity-centered framework to research